Rash; The rash started like the current ongoing itchy rash; chronic hives; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), on 10Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Epilepsy" (unspecified if ongoing); "Myocardial infarction" (unspecified if ongoing); "Surgery", start date: 08Jun2020 (unspecified if ongoing); "Multiple drug allergy" (unspecified if ongoing), notes: Aspirin, Aspirin, Aleve, Motrin, Vistaril, Diazepam, Compazine, Phenergan, Emerge, Morphine, Demerol, Fentanyl, Codeine, Dilaudid, Imitrex, Feldene, Effexor, Kytril, Neurontin, Lamictal, Depakote, Topamax, Zonegran, Klonopin, Budesonide, Gadavist, Fycompa, Flagyl, Biaxin, Toradol, Amitriptyline, Zoloft, Prozac, Celebrex, Lexapro, Paxil, Clexa, Citalopram, Tequin, Valium, Seldane, Biaxin, Flagyl, Benadryl, Fycompa, Gadavist, Budesonide, Benadryl,Zyrtec: Lot/NDC/Expiry: Unknown, caller does not have product any longer.; "Sulfa" (unspecified if ongoing), notes: Drug allergies: Sulfa; "Penicillin allergy" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Anzemet er for Migraine, reaction(s): "Drug allergies"; Keppra for Epilepsy, reaction(s): "Drug allergies"; Banzel for Epilepsy, reaction(s): "Drug allergies"; Vimpat for Epilepsy, reaction(s): "Rash"; Anzemet er for Migraine, reaction(s): "Grand mal seizure". Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Anatomical location: Left upper arm), administration date: 04Mar2021, when the patient was 69-year-old, for COVID-19 immunisation; BNT162b2 (DOSE 2, SINGLE; Anatomical location: Left upper arm), administration date: 25Mar2021, when the patient was 69-year-old, for COVID-19 immunisation. The following information was reported: RASH (non-serious), outcome "recovered"; RASH PRURITIC (non-serious), outcome "recovered", described as "The rash started like the current ongoing itchy rash"; URTICARIA (non-serious), outcome "recovered", described as "chronic hives". The events "rash", "the rash started like the current ongoing itchy rash" and "chronic hives" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash, rash pruritic, urticaria.  Additional information: It was reported that the patient got the first booster dose in Dec2021, and in Jan2022, she saw the PA allergist and dermatologist. The rash started like the current ongoing itchy rash; but the rash turned into hives. The Dermatologist told her she had chronic hives and recommended she take Allegra every day which caller did for quite a while. It took months and she said it might resolve itself, it might not; sometimes people develop not specifically from a vaccine, but develop a rash like that which turns into hives, and it is possible to have chronic hives.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.